Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC gynecological cancer cooperative group study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC gynecological cancer cooperative group study

Published:1987-06 Issue:6 Volume:23 Page:867-869
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

George M.,Scotto V.,Carnino F.,Dodion P.,Ten Bokkel Huinink W.W.,Rotmensz N.,Vermorken J.B.

Publisher

Elsevier BV

Subject

Oncology

Reference8 articles.

1. 1,2,4-Triglycidyl urazol or TGU (NSC 332488): a new antineoplastic agent;Atassi,1982

2. 1,2,4-Triglycidyl urazol (TGU, NSC 332488, I.N.N.: anaxirone): a new chemotherapeutic agent;Hilgard;Cancer Treat Rev,1984

3. Phase I study of 1,2,4-triglycidyl urazol (TGU, NSC 332488);Hansen,1984

4. Phase I trial of 1,2,4-triglycidyl urazol (TGU, NSC 332488): a new trieposide;Hansen;Eur J Cancer Clin Oncol,1985

5. Clinical and pharmacokinetic phase I study on 1,2,4-triglycidyl urazon (TGU, NSC 332488);Soukop,1984

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of High-Dose 1,2,4-Triglycidylurazol in Preparative Regimens for Bone Marrow Transplantation: Preclinical Evaluation and First Clinical Results;Acute Leukemias;1992

2. High-dose 1,2,4-triglycidylurazol given in regimens preparatory to bone marrow transplantation;Cancer Chemotherapy and Pharmacology;1991

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP